Selective loss of chemokine receptor expression on leukocytes after cell isolation

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Nieto, Juan C ^a   Cantó, Elisabet ^a   Zamora, Carlos ^a   Ortiz, M Angels ^a   Juárez, Cándido ^a   Vidal, Silvia ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR4; FICOLL; ANTICOAGULANT AGENT; LIPOPOLYSACCHARIDE;

ARTICLE; CELL FATE; CELL ISOLATION; CELL SURFACE; CONTROLLED STUDY; DENSITY GRADIENT; ENDOCYTOSIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; LEUKOCYTE; LYMPHOCYTE; MIGRATION INHIBITION; MONOCYTE; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; ANIMAL; CELL CULTURE; CELL MOTION; CELL SEPARATION; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; TIME;

ANIMALS; ANTICOAGULANTS; CELL MOVEMENT; CELL SEPARATION; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MONOCYTES; RECEPTORS, CHEMOKINE; STAINING AND LABELING; TIME FACTORS;

EID: 84857756869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031297     Document Type: Article

References (29)

1. Murphy PM, (2002) International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54: 227-229.
2. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, et al. (1998) Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A 95: 9448-9453.
3. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR, (1998) Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393: 595-599.
4. Ebert LM, Schaerli P, Moser B, (2005) Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 42: 799-809.
5. D'Amico G, Frascaroli G, Bianchi G, Transidico P, Doni A, et al. (2000) Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol 1: 387-391.
6. Penton-Rol G, Polentarutti N, Luini W, Borsatti A, Mancinelli R, et al. (1998) Selective inhibition of expression of the chemokine receptor CCR2 in human monocytes by IFN-gamma. J Immunol 160: 3869-3873.
7. Xu L, Khandaker MH, Barlic J, Ran L, Borja ML, et al. (2000) Identification of a novel mechanism for endotoxin-mediated down-modulation of CC chemokine receptor expression. Eur J Immunol 30: 227-235.
8. Xu L, Rahimpour R, Ran L, Kong C, Biragyn A, et al. (1997) Regulation of CCR2 chemokine receptor mRNA stability. J Leukoc Biol 62: 653-660.
9. Sica A, Saccani A, Borsatti A, Power CA, Wells TN, et al. (1997) Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J Exp Med 185: 969-974.
10. Arias MA, Pantoja AE, Jaramillo G, Paris SC, Shattock RJ, et al. (2006) Chemokine receptor expression and modulation by Mycobacterium tuberculosis antigens on mononuclear cells from human lymphoid tissues. Immunology 118: 171-184.
11. Juffermans NP, Weijer S, Verbon A, Speelman P, van der Poll T, (2002) Expression of human immunodeficiency virus coreceptors CXC chemokine receptor 4 and CC chemokine receptor 5 on monocytes is down-regulated during human endotoxemia. J Infect Dis 185: 986-989.
12. Phillips RJ, Lutz M, Premack B, (2005) Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J Inflamm (Lond) 2: 14.
13. Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM, (1998) Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 72: 4962-4969.
14. Rossol M, Pierer M, Arnold S, Keysser G, Burkhardt H, et al. (2009) Negative association of the chemokine receptor CCR5 d32 polymorphism with systemic inflammatory response, extra-articular symptoms and joint erosion in rheumatoid arthritis. Arthritis Res Ther 11: R91.
15. Afzal AR, Kiechl S, Daryani YP, Weerasinghe A, Zhang Y, et al. (2008) Common CCR5-del32 frameshift mutation associated with serum levels of inflammatory markers and cardiovascular disease risk in the Bruneck population. Stroke 39: 1972-1978.
16. Liao F, Rabin RL, Smith CS, Sharma G, Nutman TB, et al. (1999) CC-chemokine receptor 6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein 3 alpha. J Immunol 162: 186-194.
17. Fung E, Esposito L, Todd JA, Wicker LS, (2010) Multiplexed immunophenotyping of human antigen-presenting cells in whole blood by polychromatic flow cytometry. Nat Protoc 5: 357-370.
18. Panaro MA, Mitolo V, (1999) Cellular responses to FMLP challenging: a mini-review. Immunopharmacol Immunotoxicol 21: 397-419.
19. Hernandez-Campo PM, Martin-Ayuso M, Almeida J, Lopez A, Orfao A, (2002) Comparative analysis of different flow cytometry-based immunophenotypic methods for the analysis of CD59 and CD55 expression on major peripheral blood cell subsets. Cytometry 50: 191-201.
20. Tamul KR, Schmitz JL, Kane K, Folds JD, (1995) Comparison of the effects of Ficoll-Hypaque separation and whole blood lysis on results of immunophenotypic analysis of blood and bone marrow samples from patients with hematologic malignancies. Clin Diagn Lab Immunol 2: 337-342.
21. Fearon DT, Collins LA, (1983) Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J Immunol 130: 370-375.
22. Berhanu D, Mortari F, De Rosa SC, Roederer M, (2003) Optimized lymphocyte isolation methods for analysis of chemokine receptor expression. J Immunol Methods 279: 199-207.
23. Fantuzzi L, Borghi P, Ciolli V, Pavlakis G, Belardelli F, et al. (1999) Loss of CCR2 expression and functional response to monocyte chemotactic protein (MCP-1) during the differentiation of human monocytes: role of secreted MCP-1 in the regulation of the chemotactic response. Blood 94: 875-883.
24. Arenzana-Seisdedos F, Virelizier JL, Rousset D, Clark-Lewis I, Loetscher P, et al. (1996) HIV blocked by chemokine antagonist. Nature 383: 400.
25. Mueller A, Kelly E, Strange PG, (2002) Pathways for internalization and recycling of the chemokine receptor CCR5. Blood 99: 785-791.
26. Berlin I, Higginbotham KM, Dise RS, Sierra MI, Nash PD, (2010) The deubiquitinating enzyme USP8 promotes trafficking and degradation of the chemokine receptor 4 at the sorting endosome. J Biol Chem 285: 37895-37908.
27. Signoret N, Hewlett L, Wavre S, Pelchen-Matthews A, Oppermann M, et al. (2005) Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent. Mol Biol Cell 16: 902-917.
28. Newhall KJ, Diemer GS, Leshinsky N, Kerkof K, Chute HT, et al. (2010) Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots. Clin Chem 56: 1483-1491.
29. Nasser MW, Raghuwanshi SK, Grant DJ, Jala VR, Rajarathnam K, et al. (2009) Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. J Immunol 183: 3425-3432.